Folic Acid-Functionalized β-Cyclodextrin for Delivery of Organelle-Targeted Peptide Chemotherapeutics in Cancer DOI

Hae Won Ok,

Seongeon Jin,

Gaeun Park

et al.

Molecular Pharmaceutics, Journal Year: 2024, Volume and Issue: 21(9), P. 4498 - 4509

Published: July 29, 2024

Recent emphasis on the design of drug delivery systems typically involves effective transport a pharmaceutical substance to disease site with desired therapeutic efficacy and minimal cytotoxicity. Organelle-targeted peptides have become an integral part designing important class prodrug/prodrug assemblies for new supramolecular therapeutics owing their favorable biocompatibility, synthetic ease, tunability aggregation behavior, functionalization site-specificity. However, it is still limited due low selectivity. We designed folic acid-functionalized β-cyclodextrin (FA-CD) as platform specific selective organelle-targeted (such microtubule, lysosome, mitochondria) peptide chemotherapeutics folate receptor (FR) overexpressing cancer cell lines. Low toxicity was found FA-CD inclusion complex in FR-negative normal cells, but superior inhibition tumor growth no vivo xenograft model.

Language: Английский

Ultrasound-Activated Copper Matrix Nanosonosensitizer for Cuproptosis-Based Synergy Therapy DOI
Qiao Yu, Jie Zhou,

Qianqian Tao

et al.

ACS Applied Bio Materials, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 30, 2025

Cuproptosis exhibits enormous application prospects in treatment. However, cuproptosis-based therapy is impeded by the limited intracellular copper ions, nonspecific delivery, uncontrollable release, and chelation of endogenous overproduced glutathione (GSH). In this work, an ultrasound-triggered nanosonosensitizer (p-TiO2–Cu(I)) was constructed for Cu(I) on-demand GSH consumption, deeper tissue response. When nanomedicine internalized into tumor cells, ultrasound (US) induced to produce reactive oxygen species (ROS) achieve sonodynamic (SDT). GSH, acting as a hole trapping agent, improved efficiency SDT. Meanwhile, downgrade beneficial cuproptosis oxidative damage-based SDT return. What more, US could regulate release behavior Cu(I). bonded mitochondrial proteins then aggregated lipoylated protein, bringing about turbulence tricarboxylic acid cycle. The combination showed high matching induce efficient may inspire other designs.

Language: Английский

Citations

0

A Visible-Light Photocatalysis/Hydrolysis Hydrogen-Generating Nanoplatform for Dynamic Inflammation Management via Immune Metabolism Orchestration during Wound Repair DOI

Zhaoyu Xu,

Yang Yang,

Xinhui Li

et al.

ACS Applied Materials & Interfaces, Journal Year: 2025, Volume and Issue: unknown

Published: March 21, 2025

Effective management of inflammation is one the promising strategies to prevent formation chronic wounds. Despite hydrogen being a prospective molecule for anti-inflammatory effects, on-demand delivery that could synchronize with dynamic stages has yet remained unaddressed. Moreover, its specific immunomodulatory mechanisms are still veiled. In this study, we introduced ISO-ZIF-8@AB, hydrogen-generating nanoplatform integrated visible-light photocatalysis and hydrolysis reactions achieve controllable release on demand, functioning an initial peak following sustained release. With ISO-ZIF-8@AB further loaded into aligned ECM-like scaffold, complex significantly alleviated prevented protracted unhealing. The bulk-RNA sequencing combined single-cell RNA revealed treatment effectively reduced excessive aggregation infiltration innate immune cells. Specifically, proportion Ptgs2+Nos2+ pro-inflammatory macrophages (PIMs) by mitigating mitochondrial stress suppressing HIF-1α-induced glycolysis, immune-metabolic regulation which harmful crosstalk between PIMs hypodermal fibroblasts facilitated extracellular matrix production accompanied ultimate wound repair. Overall, study presented strategy in terms timing rate, discussions regarding underlying therapy.

Language: Английский

Citations

0

Synergistic Antiproliferative Activity of Newly Synthesized Benzimidazole-Based Silver(I) Complexes on MCF-7 and T47D Cell Lines, CT-DNA Interactions Supported by Computational Studies DOI Creative Commons

Naima Munir,

Nevın Gürbüz, Gul-e-Saba Chaudhry

et al.

ACS Omega, Journal Year: 2025, Volume and Issue: unknown

Published: March 28, 2025

This article reports the synthesis, characterization, and antitumor properties of newly synthesized benzimidazole-based Ag(I)-(BNHCs) complexes from their proligands. All compounds underwent comprehensive characterization using techniques such as 1H, COSY, 13C NMR, IR spectroscopy, electrospray ionization (ESI)-mass, elemental, single-crystal X-ray diffraction (XRD) analysis. Density functional theory (DFT) studies were carried out to observe electronic effects bound ligands modulate selectivity reactivity silver complexes. Time-dependent DFT (TD-DFT) assessed optical further highlighted by orbital contributions with oscillator strengths. tested against breast cancer MCF-7 T47D cell lines. The synergistic benzimidazole-incorporated aryl constituent structuring also observed. Nearly all have been found be promising anticancer agents added benefit low cytotoxic toward normal cells. Intriguingly, [AgL 4 (Cl)] exhibited best activity among our screened IC50 values for both 9 ± 1.04 11 1.41, respectively. apoptosis mode death was confirmed phosphatidylserine exposure annexin V/PI staining imaging method. CT-DNA interactions most active complex ([AgL (Cl)]) its proligand (HL (Cl)) support compound-DNA interaction. Strong DNA binding affinities (K b) through electrostatic intercalation modes induced structural changes in DNA. Moreover, molecular docking comprehend possible various receptors EGFR (epidermal growth factor receptor), VEGFR2 (vascular endothelial receptors), FGFR (fibroblast SRC (proto-oncogene tyrosine kinase protein) family serves crucial cancer.

Language: Английский

Citations

0

Multi-pathway copper metabolisms regulation based on an engineered copper/ferrous nanoplatform for enhanced tumor cuproptosis therapy DOI

Yun Gao,

Renlu Han, Zhen Guo

et al.

Colloids and Surfaces B Biointerfaces, Journal Year: 2025, Volume and Issue: unknown, P. 114682 - 114682

Published: April 1, 2025

Language: Английский

Citations

0

Nanoarchitecting intelligently encapsulated designs for improved cancer therapy DOI Creative Commons

Ying‐Tong Ye,

Hong‐Ying Xia,

Jie Li

et al.

Frontiers in Bioengineering and Biotechnology, Journal Year: 2025, Volume and Issue: 13

Published: May 1, 2025

Despite the success in exploring various aspects of origination and therapeutic strategies, cancer has remained one most dreadful metabolic disorders due to failure eradicate tumors comprehensively frequent recurrence because acquired resistance drugs. Recently, several advancements have been evidenced fabrication smart nanocarriers encapsulated with multiple components. Several reasons for nanoencapsulation include enhancement bioavailability drugs, precise targetability reduce adverse effects on normal cells, ability enable controlled drug release rates at tumor sites. In addition, these protect cargo from deactivation, responsively delivering it based physiological or pathological characteristics tumors. this review, we present approaches therapy, including organic materials, inorganic components, their composites, as well biomembrane-based strategies. These along practical applications potential treatment, are discussed depth, highlighting advantages disadvantages, aiming reveal ultimate prospects enhancing delivery efficiency targeted therapy.

Language: Английский

Citations

0

Design and Applications of Polymersomes for Oral Drug Administration DOI Creative Commons
Wing‐Fu Lai

ACS Applied Materials & Interfaces, Journal Year: 2025, Volume and Issue: unknown

Published: May 15, 2025

Polymersomes are nanostructures consisting of a hollow aqueous compartment enclosed by coating amphiphilic block copolymers. Owing to the entangled nature their membrane, polymersomes exhibit higher mechanical stability than some other extensively studied such as liposomes. This also enables properties polymersome membrane be more easily tuned meet practical needs, making promising carriers for drug delivery. Since turn last century, use has been exploited in diverse areas, ranging from protein therapy medical imaging. Yet, discussions exploring opportunities and challenges development oral administration have scant. review addresses this gap offering snapshot current advances design, fabrication, carriers. It is hoped that will not only highlight potential but shed light on determining wider clinical forthcoming decades.

Language: Английский

Citations

0

Cuproptosis-Driven Nanostrategies: Synergistic Nanoplatforms for Tumor Microenvironment Reprogramming and Enhanced Anticancer Efficacy DOI Creative Commons
Haipeng Cheng, Lin Zhao, Jing Cai

et al.

Materials Today Bio, Journal Year: 2025, Volume and Issue: unknown, P. 101894 - 101894

Published: May 1, 2025

Language: Английский

Citations

0

A copper missile-triggered power coalescence and death vortex within tumor cell mitochondria for synergistic cuproptosis/phototherapy/chemotherapy DOI
Yicheng Jiang, Shuhan He, Xiang Niu

et al.

Nanoscale, Journal Year: 2024, Volume and Issue: 16(34), P. 15967 - 15983

Published: Jan. 1, 2024

The CCTH nanoparticles trigger power coalescence and death vortex within tumor cell mitochondria, producing potent anti-tumor efficacy through cuproptosis/phototherapy/chemotherapy synergistic therapy.

Language: Английский

Citations

3

Multistage microfluidic assisted Co-Delivery platform for dual-agent facile sequential encapsulation DOI
Shixin Li, Bing Yang,

Liang Ye

et al.

European Journal of Pharmaceutics and Biopharmaceutics, Journal Year: 2024, Volume and Issue: unknown, P. 114616 - 114616

Published: Dec. 1, 2024

Language: Английский

Citations

3

Redox homeostasis disruptors enhanced cuproptosis effect for synergistic photothermal/chemodynamic therapy DOI
Zhen Liu, Junhong Ling,

Nan Wang

et al.

Journal of Colloid and Interface Science, Journal Year: 2024, Volume and Issue: 678, P. 1060 - 1074

Published: Aug. 31, 2024

Language: Английский

Citations

2